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Left ventricular  hypertrophy  (LVH),  detected  by  standard  12-lead  electrocardiogram
(ECG)  or  echocardiography,  is  a  cardinal  manifestation  of  preclinical  organ  damage  related
to  hypertension,  and  is  a  strong  predictor  of  cardiovascular  morbidity  and  mortality  in
several  clinical  settings  [1].  Regression  of  ECG  or  echocardiographic  LVH  has  been  shown
to  occur  during  long-term  effective  antihypertensive  treatment,  and  to  drive  a  variety  of
beneﬁcial  effects  on  left  ventricular  function,  myocardial  tissue  network,  coronary  reserve
and  arrhythmias,  thus  resulting  in  an  improved  cardiovascular  prognosis  [2].  An  ECG  isMOTS  CLÉS
Hypertrophie
ventriculaire  gauche  ;
Électrocardiogramme  ;
Onde  R  en  aVL
generally  considered  as  the  ﬁrst  and  mandatory  investigation  that  should  be  carried  out
in  each  hypertensive  individual,  to  detect  LVH,  ischaemia,  conduction  abnormalities,  left
atrial  dilatation  and  arrhythmias  —– particularly  atrial  ﬁbrillation;  its  sensitivity  to  detect
LVH  is  usually  considered  to  be  low  (30—50%),  while  its  speciﬁcity  is  high  (90%)  [3].
Abbreviations: ECG, Electrocardiogram; LVH, Left ventricular hypertrophy; LVMI, Left ventricular mass index; MRI, Magnetic resonance
imaging; RaVL, R wave in aVL lead; TTE, Transthoracic echocardiography.
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Table  1  Sensitivity  and  speciﬁcity  of  different  cut-offs  for  R  wave  in  aVL  lead  to  predict  left  ventricular  hypertrophy  and  incident  cardiovascular  eventsa.
Cut-off  Sensitivity  Speciﬁcity  %  above
cut-off
Sensitivity  Speciﬁcity  %  above
cut-off
Sensitivity  Speciﬁcity  %  above
cut-off
Sensitivity  Speciﬁcity  %  above
cut-off
Prediction  of  LVH  by  TTEb Prediction  of  LVH  by  CMRc Prediction  of  CV  events  Prediction  of  CV  mortality
4  mm  78  53  56  81  46  56  78  39  56  63  17  55
6  mm  59  76  36  65  72  33  56  59  36  44  19  39
8  mm  38  87  21  42  84  18  36  76  21  29  34  24
9  mm  27  91  14  35  90  12  26  83  14  23  43  18
10  mm  27  91  9  27  94  7  18  89  9  17  57  13
Data are %. CMR: cardiac magnetic resonance; CV: cardiovascular; LVH: left ventricular hypertrophy; LVMI: left ventricular mass index; TTE: transthoracic echocardiography.
a Adapted from [11—13].
b LVMI > 51 g/m2.7.
c LVMI > 67 g/m2 for women and > 83 g/m2 for men.
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The  QRS  voltage  increases  with  both  thickening  of  the
wall  (pressure  overload)  and  dilatation  of  the  chamber  (vol-
ume  overload)  of  the  left  ventricle.  The  2009  American
Heart  Association/American  College  Cardiology  Founda-
tion/Heart  Rhythm  Society  listed  as  many  as  35  ECG-LVH
criteria  based  on  the  following:  limb  lead  voltage;  pre-
cordial  lead  voltage;  combination  of  limb  and  precordial
voltage;  combinations  of  voltage  and  non-voltage  criteria;
and  speciﬁc  criteria  for  patients  with  left  anterior  fascicu-
lar  block  and  right  bundle  branch  block  [4].  More  practically,
recent  European  guidelines  on  hypertension  highlighted  four
indexes:  the  Sokolow-Lyon  index  (SV1  +  RV5  >  3.5  mV);  the
modiﬁed  Sokolow-Lyon  index  (largest  S-wave  +  largest  R-
wave  >  3.5  mV);  R  wave  in  aVL  lead  (RaVL)  >  1.1  mV;  and
Cornell  voltage  QRS  duration  product  (>  244  mV·ms)  [5].
Among  these  four  indexes,  the  Sokolow-Lyon  index  is  most
widely  used  by  physicians,  although  its  sensitivity  is  par-
ticularly  low  (around  30%)  [6]  and  no  correlation  has  been
observed  with  left  ventricular  mass  index  (LVMI)  in  obese
patients  [7].  By  comparison,  the  Cornell  voltage  (RaVL  +  SV3)
and  its  product  (Cornell  voltage·QRS  duration)  have  demon-
strated  better  diagnostic  value,  but  their  use  is  compounded
by  the  need  for  speciﬁc  sex  correction  [8,9].  Finally,  the
RaVL  voltage,  a  component  of  the  Cornell  index,  is  a  sim-
ple  index  of  LVH  that  is  not  currently  widely  used  [10].
Recent  studies  have  demonstrated  many  advantages  of  this
last  index,  including  its  good  performance  in  detecting  LVH
[11—14],  which  supports  its  revival.
RaVL  is  a  limb  voltage,  well  aligned  with  the  depolar-
ization  axis  of  the  left  ventricle.  Generally,  RaVL  increases
when  the  heart  is  horizontal  —– an  anatomical  position  fre-
quently  present  in  old  and  obese  patients  —– or  in  the
presence  of  LVH  or  left  ventricle  enlargement  [10,13].  Yet,
RaVL  appears  to  be  correlated  with  LVMI  assessed  by  mag-
netic  resonance  imaging  (MRI),  even  after  adjustment  for
age  and  body  mass  index  [11].
The  ﬁrst  strength  of  the  RaVL  index  (which  probably  con-
tributes  to  its  good  performance)  is  its  better  inter-reader
reproducibility  and  lower  variability  between  two  succes-
sive  ECGs  compared  with  SV3,  the  Sokolow-Lyon  index  and
the  Cornell  index  [13].  These  features  probably  result  from
the  fact  that  RaVL  does  not  require  thoracic  leads,  which  is
undoubtedly  a  source  of  variability,  particularly  in  women.
The  second  interesting  feature  of  RaVL  is  its  univocal
threshold  at  1.0  mV  to  detect  LVH,  recently  demonstrated  in
comparison  with  cardiac  MRI  [11].  This  cut-off  was  observed
independent  of  sex,  body  mass  index,  previous  myocar-
dial  infarction,  ethnicity  and  conduction  disorder.  Using  this
threshold,  more  than  80%  of  patients  without  myocardial
infarction  were  correctly  classiﬁed  according  to  their  LVH
status.  Interestingly  for  an  ECG  LVH  index,  RaVL  also  had
good  sensibility  to  rule  out  LVH  below  0.5  mV  [11].  The
grey  zone,  between  0.5  and  1.0  mV  may  be  an  indication  to
perform  transthoracic  echocardiography  (TTE)  to  reﬁne  the
classiﬁcation  of  these  patients  [15].  Of  note,  several  studies
that  previously  tested  RaVL  in  comparison  with  TTE  reported
a  lower  cut-off  value  at  0.6  mV  most  of  the  time  [12,14,16].
This  lower  threshold  was  associated  with  a  better  sensitivity
but  a  lower  speciﬁcity.The  third  strength  of  RaVL  is  its  prognostic  value  in
hypertensive  patients,  which  was  recently  analyzed  in  three
studies  [12—14].  In  2009,  Verdecchia  et  al.  demonstrated279
he  independent  prognostic  value  of  RaVL  in  the  predic-
ion  of  cardiovascular  events  in  a  cohort  of  hypertensive
atients  without  ECG  LVH  (typical  strain  or  Cornell  volt-
ge)  [14]. The  optimal  prognostic  threshold  was  deﬁned
t  5.7  mm.  A  few  years  later,  these  data  were  conﬁrmed
n  a Bordeaux  cohort  [13]. With  an  optimal  threshold  of
.0  mm,  RaVL  predicted  cardiovascular  events  better  than
he  Sokolow-Lyon  and  Cornell  indexes.  Another  analysis  in
he  OLD-HTA  Lyon  cohort  demonstrated  the  same  trend.
aVL  was  independently  associated  with  cardiovascular  and
ll-cause  mortality,  with  optimal  cut-offs  at  6.0  and  8.0  mm,
espectively  [12].  After  excluding,  in  turn,  patients  with
 positive  Sokolow-Lyon  index,  Cornell  voltage  or  Cornell
roduct,  the  results  remained  statistically  signiﬁcant,  mean-
ng  that  RaVL  was  still  able  to  pick  up  high-risk  patients  when
ther  classical  and  more  sophisticated  indices  failed.
For  an  integrative  view,  Table  1  summarizes  different  cut
aVL  cut-offs  for  predicting  LVH  and  cardiovascular  events.
he  choice  of  a  high  threshold  >  1.0  mm  is  related  to  a  speci-
city  of  90%  to  detect  LVH  and  also  to  predict  cardiovascular
vents.  However,  we  observed  this  situation  in  only  10%
f  hypertensive  patients.  On  the  contrary,  a lower  thresh-
ld  <  0.6  mm  can  be  chosen  to  rule  out  patients  at  low  risk.
etween  these  two  cut-offs,  physicians  probably  need  addi-
ional  imaging  methods  to  correctly  stratify  the  risk  of  the
emaining  patients.
For  all  these  reasons,  RaVL  should  now  be  the  ﬁrst  index
sed  to  detect  LVH  during  the  initial  work-up  of  hyperten-
ive  patients;  it  should  replace  the  very  popular  but  useless
okolow  index,  and  it  is  our  role  to  promote  RaVL  among  the
edical  community  and  the  medical  students.
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